Clinical experience with ouabain administered in small divided doses in the monitored patient.
D000284:Administration, Oral; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D004077:Digoxin / Q000008:administration & dosage / Q000627:therapeutic use; D004562:Electrocardiography; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000188:drug therapy; D010042:Ouabain / Q000008:administration & dosage* / Q000627:therapeutic use / Q000633:toxicity; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D010042:Ouabain; D004077:Digoxin